Spirax Group, the Gloucestershire-based industrial engineering firm, has reiterated its full-year guidance after delivering a resilient half-year performance, with revenues climbing five per cent to £863.8 million and adjusted operating profit rising to £171.1 million from £158.8 million a year earlier.
Strong Momentum in Key End Markets
The FTSE 100 company, known for its steam management systems, said on Tuesday (August 11) that continuing momentum in end markets such as semiconductors and biopharm, along with a robust order book, underpins expectations for second-half revenue and profit growth.
Nimesh Patel, group chief executive, attributed the performance to the strength of the company's business model. "We have again delivered resilient mid-single-digit organic growth in revenue and profit, well ahead of IP," he said. "Driving growth ahead of our markets, in spite of external conditions, is now becoming embedded in how we operate and demonstrates the strengths of our business model and strategic positioning in diversified and attractive end markets."
Strategic Growth and Medium-Term Targets
Mr Patel highlighted that the 'Together for Growth' strategy is strengthening the group's differentiated business model, with competitive leadership and resilience driving organic growth at high margins and improving returns on capital. "We remain on track to deliver the medium-term targets we set out for the Group in October 2024; and above these targets in the longer term," he added.
The company's interim dividend was increased by three per cent to 50.4p per share, reflecting confidence in its financial position.
Operational Scale and Restructuring Savings
Spirax operates through three business segments: steam thermal, electric thermal, and fluid technology. The group employs approximately 10,000 staff across 68 countries and runs 30 manufacturing plants worldwide.
Last year, Spirax announced a restructuring programme expected to deliver annual savings of around £35 million, which will be reinvested to support future organic growth. The cash costs associated with the programme were largely incurred in 2025, allowing the company to benefit from the savings in the current year.
The resilient first-half results and reaffirmed guidance underscore Spirax's ability to navigate external challenges while maintaining growth momentum, positioning it well for the remainder of the year.
